Gw&K Investment Management, LLC Hutchmed (China) LTD Transaction History

Gw&K Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$15.52 - $35.65 $26,461 - $60,783	-1,705 Reduced 83.17%	345 $7,000
Q4 2021 Feb 11, 2022	SELL	$28.89 - $35.33 $5,344 - $6,536	-185 Reduced 8.28%	2,050 $72,000
Q3 2021 Nov 10, 2021	SELL	$35.66 - $42.94 $3,209 - $3,864	-90 Reduced 3.87%	2,235 $82,000
Q1 2021 May 11, 2021	BUY	$27.01 - $36.8 $270 - $368	10 Added 0.43%	2,325 $66,000
Q4 2020 Feb 05, 2021	BUY	$27.51 - $34.36 $3,988 - $4,982	145 Added 6.68%	2,315 $74,000
Q3 2020 Nov 10, 2020	BUY	$25.8 - $34.61 $5,805 - $7,787	225 Added 11.57%	2,170 $70,000
Q2 2020 Aug 06, 2020	BUY	$17.65 - $28.05 $8,118 - $12,903	460 Added 30.98%	1,945 $54,000
Q1 2020 May 11, 2020	BUY	$15.19 - $29.51 $1,139 - $2,213	75 Added 5.32%	1,485 $27,000
Q4 2019 Feb 10, 2020	BUY	$17.17 - $25.95 $2,317 - $3,503	135 Added 10.59%	1,410 $35,000
Q3 2019 Nov 05, 2019	BUY	$17.84 - $22.69 $22,746 - $28,929	1,275 New	1,275 $23,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.